Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Prevention of venous thromboembolic events with low-molecular-weight heparin in the non-major orthopaedic setting: meta-analysis of randomized controlled trialsArthroscopy. 2014 Aug;30(8):987-96
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Data from 14 Level I or Level II randomized controlled trials (N=4726) was gathered in this meta-analysis. The aim of this study was to assess the efficacy of low-molecular-weight heparin venous thromboprophylaxis versus placebo/no treatment in non-major orthopaedic patients with transient reduced mobility. Findings indicated significant risk reduction of thromboembolic events with prophylactic lo...
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.Continue